CYSTAGON 150 mg, hard capsule 100 capsules
Active ingredients: Cysteamine bitartrate, Cysteamine
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule100 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CYSTAGON 150 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 100 gélule(s)
- Marketing authorisation holder
- RECORDATI RARE DISEASES
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1998
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64781800CIP75609734CIP133400956097340Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BITARTRATE DE MERCAPTAMINEgélule | 441,72 mg · une gélule | SA |
| CYSTÉAMINEgélule | 150 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.